Orphan Drugs & Rare Diseases- Innovative Strategies for Getting Orphan Drugs to Where They Are Needed

-

The call to treat rare diseases has become increasingly greater around the world than ever before. Supportive organisations including patient groups, national health authorities, health trusts, academia, HTAs, pharmaceutical and biotechnical companies are now progressively growing in numbers and sophistication in their approaches to medicinal care for those with rare and ultra-rare diseases.

SMi’s Orphan Drugs & Rare Diseases conference will present briefings from key opinion leaders, those with hands-on experience of regulating new drug discoveries, companies that have already developed advanced orphan drugs & successfully been granted orphan medicine status and selected experts in the field. Our expert speakers will offer unique insights into cutting-edge international developments taking place in: expanding the reach of medicine to previously untreatable and unreachable patients with rare diseases; different regulatory and policy environments; new drug discoveries; innovative business strategies & funding & financing models, and the importance of partnerships with patient groups and those at the point-of-care.

Key benefits of attending:

• Learn about health technology assessment protocols and market access in the EU and globally
• Network with key regulators of orphan medicines and policy makers for national rare disease treatment
• Discover successful funding, financing and economic models for orphan drug development and translational research
• Analyse industry case studies showing how R&D and market access costs can be reduced
• Understand the latest developments in ultra-rare diseases studies and new medicines for them
• Explore how organisations are merging research, resources and expertise in the race to cure rare diseases

Hear keynote addresses from:

• Dr. Edmund Jessop, Medical Advisor, National Commissioning Group for Highly Specialised Services, NHS
• Josie Godfrey, Head of Policy and Coordination, AGNSS

• Stephen Nutt, Executive Officer, Rare Disease UK

• Carlos R. Camozzi, MD, PhD, MBA, Vice President, Chief Medical Officer, uniQure B.V.

• Marisa Jaconi, Vice-Director and Founder, Swiss Institute of Cell Therapies (SICT)

• Samantha Parker, Director of External Affairs and Rare Disease Partnerships, Orphan Europe


Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

8 Oct 2012



All Upcoming Events
1 2 Next 
9th Annual Pharmaceutical Analysis Conference25 Sep 2017
14th Confocal Raman Imaging Symposium25 Sep 2017
6th Annual Cancer Vaccines Conference27 Sep 2017
Biosimilars & Biobetters 201727 Sep 2017
ELRIG: Drug Discovery 20173 Oct 2017
Drug Discovery 20173 Oct 2017
7th Annual EPP Life Science Pricing Forum4 Oct 2017
3rd Drug Discovery Innovation Programme5 Oct 2017
Lab Asia 201710 Oct 2017
The 17th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2017)10 Oct 2017
Pharmaceutical Pricing and Market Access 201711 Oct 2017
Next-Generation Antibodies and Protein Analysis (2nd Edition)16 Oct 2017
11th World Drug Delivery Summit16 Oct 2017
4th International Conference on Past and Present Research Systems of Green Chemistry16 Oct 2017
7th Annual Orphan Drugs and Rare Diseases UK18 Oct 2017
6th Global Congress on Mass Spectrometry (Mass Spectra 2017)18 Oct 2017
Pain Medicine 201719 Oct 2017
International Conference on Biotech Pharmaceuticals23 Oct 2017
Macrophage Biology in the Single-Cell Era26 Oct 2017
Preclinical Development Operations Summit 201731 Oct 2017
BioData World Congress 20172 Nov 2017
5th Microbiome R&D and Business Collaboration Forum: USA2 Nov 2017
The 2nd Probiotics Congress: USA2 Nov 2017
4th Drug Discovery Innovation Programme2 Nov 2017
Plant Genomics & Gene Editing Congress: USA2 Nov 2017
Partnerships in Biocontrol, Biostimulants & Microbiome Congress2 Nov 2017
Recent Advances in Food Analysis (RAFA 2017)7 Nov 2017
Superbugs & Superdrugs USA13 Nov 2017
Pharmaceutical Microbiology East Coast13 Nov 2017
4th Biosimilars North America15 Nov 2017

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement